Dow Up 0.04% Nasdaq Up 0.34%

Omeros Corporation (OMER)

-NasdaqGM
14.92 Up 0.01(0.07%) 10:52AM EDT - Nasdaq Real Time Price
Prev Close:14.91
Open:15.00
Bid:14.86 x 800
Ask:14.92 x 100
1y Target Est:32.80
Beta:1.27
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:14.60 - 15.00
52wk Range:4.99 - 18.80
Volume:89,864
Avg Vol (3m):398,249
Market Cap:507.21M
P/E (ttm):N/A
EPS (ttm):-1.54
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OMERUp 0.07%507.21M
ACADUp 9.13%2.60B
ALKSDown 1.50%6.43B
HRTXUp 2.56%278.40M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):993.86
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.19
Quarterly EPS Est (Sep-14) :-0.64
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-0.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes products targeting inflammation, coagulopathies, and disorders of the central nervous system. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback